本页面由Tiger Trade Technology Pte. Ltd.提供服务

Stoke Therapeutics, Inc.

32.85
-0.8500-2.52%
盘后32.850.00000.00%17:10 EDT
成交量:50.06万
成交额:1,650.66万
市值:19.43亿
市盈率:-282.55
高:34.54
开:33.79
低:32.36
收:33.70
52周最高:40.22
52周最低:5.35
股本:5,915.08万
流通股本:4,393.78万
量比:0.34
换手率:1.14%
股息:- -
股息率:- -
每股收益(TTM):-0.1163
每股收益(LYR):-0.1163
净资产收益率:-2.37%
总资产收益率:-3.73%
市净率:5.51
市盈率(LYR):-282.55

数据加载中...

2024/03/28

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/03/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/25

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/25

重要事件披露

Form 8-K - Current report
2024/03/25

重要事件披露

Form 8-K - Current report
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/26

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/26

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/15

重要事件披露

Form 8-K - Current report
2023/12/01

重要事件披露

Form 8-K - Current report
2023/11/18

SEC问询函

Form CORRESP - Correspondence
2023/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/07

重要事件披露

Form 8-K - Current report
2023/11/07

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals